Percutaneous treatment in mitral valve regurgitation

Paolo Denti, Alfieri Ottavio

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Percutaneous mitral valve intervention (PMVI) has become an alternative therapeutic option for patients who are not eligible for conventional surgical treatment of mitral regurgitation (MR). PMVI can correct MR by means of the direct or indirect reduction of mitral annular dilatation, or through intervention on the primary or secondary abnormalities of the mitral apparatus. Among PMVI techniques, the MitraClip system, which is able to reproduce the edge-to-edge surgical procedure, is the only percutaneous therapeutic approach that can presently be considered clinically validated.

Original languageEnglish
Title of host publicationSecondary Mitral Valve Regurgitation
PublisherSpringer-Verlag London Ltd
Pages153-164
Number of pages12
ISBN (Print)9781447164883, 9781447164876
DOIs
Publication statusPublished - Jan 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Percutaneous treatment in mitral valve regurgitation'. Together they form a unique fingerprint.

Cite this